BNF 84 (British National Formulary) September 2022-March 2023: 84: September 2022 - March 2023

Product Information

BNF is published in print but interim updates are issued and published in the digital versions of BNF. The age of children under 12 years and of adults over 60 years must be printed in the box available; the age of children under 5 years should be printed in years and months. While the BNF has the valuable support of expert advisers and the Joint Formulary Committee, the recommendations made may be subject to a further level of scrutiny through peer review to ensure they reflect best practice. Many of the non-proprietary titles used in this book are titles of monographs in the European Pharmacopoeia, British Pharmacopoeia, or British Pharmaceutical Codex 1973.

Less detail is given on areas such as obstetrics, malignant disease, and anaesthesia since it is expected that those undertaking treatment will have specialist knowledge and access to specialist literature. Consensus guidelines The advice in the BNF is checked against consensus guidelines produced by expert bodies.To be clear on the precise licensing status of specific medicinal forms, practitioners should check the product literature for the particular product being prescribed or dispensed. The dose panel also contains, where known, an indication of pharmacokinetic considerations that may affect the choice of dose, and dose equivalence information, which may aid the selection of dose when switching between drugs or preparations. Drug class monographs – where substantial amounts of information are common to all drugs within a drug class (e. A new offence of driving, attempting to drive, or being in charge of a vehicle, with certain specified controlled drugs in excess of specified limits, came into force on 2nd March 2015. For all biological medicines, adverse reaction reports should clearly state the brand name and the batch number of the suspected medicine.

The presence of benzyl alcohol and polyoxyl castor oil (polyethoxylated castor oil) in injections is indicated in the BNF.updated guidance for immunisation of neonates in-line with Public Health England/UK Health Security Agency recommendations. All comments are looked at with care and, where necessary, additional information and expert advice are sought. The quantity to be supplied may be stated by indicating the number of days of treatment required in the box provided on NHS forms.